Liudmila M. Tsybalova
Russian Ministry Of Health, Prof. Popov St. 15/17
Saint Petersburg, SPE 197376, Russian Federation
Saint Petersburg, SPE 197376, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Inserting CTL Epitopes of the Viral Nucleoprotein to Improve Immunogenicity and Protective Efficacy of Recombinant Protein against Influenza A Virus.
Journal: Biology
Published: August 28, 2024
Influenza A Vaccine Candidates Based on Virus-like Particles Formed by Coat Proteins of Single-Stranded RNA Phages Beihai32 and PQ465.
Journal: Vaccines
Published: July 22, 2024
Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and Protect Animals from Infection.
Journal: Molecules (Basel, Switzerland)
Published: August 04, 2023
Plant-Produced Nanoparticles Based on Artificial Self-Assembling Peptide Bearing the Influenza M2e Epitope.
Journal: Plants (Basel, Switzerland)
Published: April 30, 2023
Non-invasive transcutaneous influenza immunization using vaccine-loaded vaterite particles.
Journal: Journal of materials chemistry. B
Published: April 04, 2023
Inside and outside of virus-like particles HBc and HBc/4M2e: A comprehensive study of the structure.
Inside and outside of virus-like particles HBc and HBc/4M2e: A comprehensive study of the structure.
Journal: Biophysical chemistry
Published: July 05, 2022
Influenza B: Prospects for the Development of Cross-Protective Vaccines.
Journal: Viruses
Published: April 26, 2022
Nanoparticles based on artificial self-assembling peptide and displaying M2e peptide and stalk HA epitopes of influenza A virus induce potent humoral and T-cell responses and protect against the viral infection.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: June 10, 2021
Last Updated: 09/26/2026